• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Thromb Haemost . THE ADA (AGE-D-DIMER-ALBUMIN) SCORE TO PREDICT THROMBOSIS IN SARS-CoV-2

tetano

Editor, Senior Moderator
Thromb Haemost


. 2022 Mar 4.
doi: 10.1055/a-1788-7592. Online ahead of print.
THE ADA (AGE-D-DIMER-ALBUMIN) SCORE TO PREDICT THROMBOSIS IN SARS-CoV-2


Francesco Violi[SUP] 1 [/SUP], Pasquale Pignatelli[SUP] 2 [/SUP], Annarita Vestri[SUP] 3 [/SUP], Alessandra Spagnoli[SUP] 4 [/SUP], Francesco Cipollone[SUP] 5 [/SUP], Giancarlo Ceccarelli[SUP] 6 [/SUP], Alessandra Oliva[SUP] 6 [/SUP], Maria Amitrano[SUP] 7 [/SUP], Matteo Pirro[SUP] 8 [/SUP], Gloria Taliani[SUP] 6 [/SUP], Roberto Cangemi[SUP] 6 [/SUP], Miriam Lichtner[SUP] 9 [/SUP], Francesco Pugliese[SUP] 10 [/SUP], Marco Falcone[SUP] 11 [/SUP], Mario Venditti[SUP] 10 [/SUP], Claudio Maria Mastroianni[SUP] 10 [/SUP], Lorenzo Loffredo[SUP] 12 [/SUP]



Affiliations

Abstract

Background: Severe acute respiratory syndrome coronavirus-2 (SARS-CoV2)-related pneumonia is associated with venous and arterial thrombosis . Aim of the study was to find-out a new score for predicting thrombosis in patients with SARS-CoV-2.
Methods: We included a cohort of 674 patients affected by SARS-CoV-2, not requiring intensive care units, and followed-up during the hospitalization until discharge. Routinary analyses performed at in-hospital admission included also serum albumin and D-dimer while arterial and venous thromboses were the end-points of the study.
Results: During the follow-up thrombotic events 110 were registered; patients with thrombotic events were older and had lower albumin and higher D-dimer, compared to thrombotic event-free ones. On multivariable logistic regression with step by stepwise procedure age, serum albumin, D-dimer, were independently associated with thrombotic events. The linear combination of age, D-dimer, albumin allowed to build-up the ADA score, whose AUC was 0.752 (95% CI, 0.708-0.795). ADA score was internally validated by bootstrap sampling procedure giving an AUC of 0.752 (95% CI: 0.708 - 0.794).
Conclusions: Combination of age, D-dimer, albumin in the ADA score allows identifying SARS-CoV-2 patients at higher risk of thrombotic events.
 
Back
Top Bottom